Cardiovascular benefits: Numerous studies have demonstrated that GLP-1s reduce cardiovascular risk in patients with diabetes or those at high cardiovascular risk, independent of their HbA1c levels
Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ
Clinical studies of GLP-1 therapy in women of reproductive age have not identified contraceptive failure as a concern
He looked at his pale skinny body and told me that his body was unable to absorb essential vitamins, minerals and fatty acids
Similarly, metabolomic profiling of peripheral blood mononuclear cells (PBMCs) has been proposed as a potential biomarker for predicting the response to immune checkpoint inhibitor therapy
Figure 7 For females, several pathways were also significantly affected ( Figure 8a )